Global Autotransfusion System Market - 2023-2030

Global Autotransfusion System Market - 2023-2030


Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.

Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.

Market Dynamics

An Increase in the Incidence of Vascular Surgeries is Driving the Autotransfusion System Market

The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.

For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.

The rise in Technological Advancements is Demanding the Global Autotransfusion System Market Growth

The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.

The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.

A lack of Skilled Professionals to Perform the Procedure can Hamper the Market Growth

Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.

Segment Analysis

The global autotransfusion system market is segmented based on product type, techniques, application, and end user.

The Cardiology Segment Holds the Dominant Position in the Market Over Forecast Period

Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.

For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.

Geographical Analysis

Europe accounted for 27.9% of the Market Share Owing to the Prevalence of Surgeries and Increasing Technological Advancements

Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.

For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.

Competitive Landscape

The major global players in the autotransfusion market include BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.

Why Purchase the Report?
• To visualize the global autotransfusion system market segmentation based on product type, techniques, application, and end-user, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global autotransfusion system market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in incidence of surgeries with maximum blood loss
4.1.1.2. Increase in the unavailability of the donors
4.1.2. Restraints
4.1.2.1. High cost of an autotransfusion system
4.1.3. Opportunity
4.1.3.1. Technological advancements in product development
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Impact Analysis
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Intraoperative Autotransfusion Systems*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Postoperative Autotransfusion Systems
8.4. Dual-Mode Autotransfusion Systems
8.5. Autotransfusion Accessories
9. By Techniques
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Techniques
9.1.2. Market Attractiveness Index, By Techniques
9.2. Predeposit autologous donation (PAD) *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Acute normovolaemic haemodilution (ANH)
9.4. Perioperative cell salvage (PCS)
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Orthopedic*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurology
10.4. Cardiology
10.5. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals *
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Specialty Clinics
11.4. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. U.K.
12.3.7.3. France
12.3.7.4. Spain
12.3.7.5. Italy
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technique
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Armstrong Medical.
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Beijing ZKSK Technology
14.3. Medtronic
14.4. Haemonetics
14.5. LivaNova
14.6. BD
14.7. Zimmer
14.8. Terumo BCT
14.9. Atrium Medical Corporation
14.10. Fresenius Kabi
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings